STRIMVELIS Trademark

Trademark Overview


On Monday, October 12, 2015, a trademark application was filed for STRIMVELIS with the United States Patent and Trademark Office. The USPTO has given the STRIMVELIS trademark a serial number of 86785052. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 1, 2024. This trademark is owned by Glaxo Group Limited. The STRIMVELIS trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Cell and gene therapy
strimvelis

General Information


Serial Number86785052
Word MarkSTRIMVELIS
Filing DateMonday, October 12, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 1, 2024
Registration Number5445761
Registration DateTuesday, April 17, 2018
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 30, 2018

Trademark Statements


Description of MarkThe mark consists of the word "STRIMVELIS" to the right of a circle, formed by a series of lines, with an indentation in the lower right.
Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
Indication of Colors claimedColor is not claimed as a feature of the mark.
Translation of Words in MarkThe wording "STRIMVELIS" has no meaning in a foreign language.
Goods and ServicesCell and gene therapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 1, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 1, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events


Event DateEvent Description
Friday, October 16, 2015NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, October 15, 2015NEW APPLICATION ENTERED
Thursday, October 15, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 9, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 19, 2016PUBLISHED FOR OPPOSITION
Friday, January 8, 2016ASSIGNED TO EXAMINER
Wednesday, January 13, 2016NON-FINAL ACTION WRITTEN
Wednesday, January 13, 2016NON-FINAL ACTION E-MAILED
Wednesday, January 13, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 3, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 3, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 3, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 30, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 13, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 7, 2017SOU EXTENSION 2 FILED
Wednesday, June 7, 2017SOU EXTENSION 2 GRANTED
Friday, June 9, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 19, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 14, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, December 9, 2016SOU TEAS EXTENSION RECEIVED
Friday, December 9, 2016SOU EXTENSION 1 FILED
Friday, December 9, 2016SOU EXTENSION 1 GRANTED
Wednesday, June 7, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, December 20, 2017PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Wednesday, January 10, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 30, 2018PUBLISHED FOR OPPOSITION
Tuesday, January 30, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 17, 2018REGISTERED-PRINCIPAL REGISTER
Monday, April 17, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, November 1, 2024CANCELLED SEC. 8 (6-YR)
Wednesday, December 20, 2017CASE RETURNED TO EXAMINATION
Wednesday, December 6, 2017TEAS PETITION TO AMEND BASIS RECEIVED
Wednesday, December 6, 2017TEAS PETITION TO AMEND BASIS RECEIVED
Thursday, December 14, 2017NOTICE OF ALLOWANCE CANCELLED
Monday, December 18, 2017ASSIGNED TO PETITION STAFF